NASDAQ:QLGN
Delisted

Qualigen Therapeutics Stock Insider Trading

etoro logo Buy QLGN
*Your capital is at risk
$3.21
+0 (+0%)
At Close: Feb 17, 2026

Qualigen Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 10.77M and sold 0 QLGN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 10.77M shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jul 11, 2022
Buy
Stock Option (Right to Buy)
A-Award
Broidrick Amy S.
President/cso
CEO / President 130 000
Value: $0
Jul 11, 2022
Buy
Stock Option (Right to Buy)
A-Award
Broidrick Amy S.
President/cso
CEO / President 130 000
Value: $66.8K
Jul 11, 2022
Buy
Stock Option (Right to Buy)
A-Award
Broidrick Amy S.
President/cso
CEO / President 130 000
Value: $66.8K
Jul 11, 2022
Buy
Stock Option (Right to Buy)
A-Award
Broidrick Amy S.
President/cso
CEO / President 130 000
Value: $0
Jul 11, 2022
Buy
Stock Option (Right to Buy)
A-Award
Korenberg Matthew E
Director 40 000
Value: $0
Jul 11, 2022
Buy
Stock Option (Right to Buy)
A-Award
Poirier Michael S.
Chairman And CEO
CEO / President 375 000
Value: $0
Jul 11, 2022
Buy
Stock Option (Right to Buy)
A-Award
Sinha Shishir K.
Vp, COO & Secretary
C-Suite Officer 100 000
Value: $51.4K
Jul 11, 2022
Buy
Stock Option (Right to Buy)
A-Award
Sinha Shishir K.
Vp, COO & Secretary
C-Suite Officer 100 000
Value: $0
Jul 11, 2022
Buy
Stock Option (Right to Buy)
A-Award
David Richard A.
Director
Director 40 000
Value: $20.5K
Jul 11, 2022
Buy
Stock Option (Right to Buy)
A-Award
David Richard A.
Director 40 000
Value: $0
Jul 11, 2022
Buy
Stock Option (Right to Buy)
A-Award
Kruger Kurt H
Director 40 000
Value: $0
Jul 11, 2022
Buy
Stock Option (Right to Buy)
A-Award
Emery Sidney W Jr
Director
Director 40 000
Value: $20.5K
Jul 11, 2022
Buy
Stock Option (Right to Buy)
A-Award
Emery Sidney W Jr
Director 40 000
Value: $0
Jul 11, 2022
Buy
Stock Option (Right to Buy)
A-Award
Ritter Ira E.
Director
Director 40 000
Value: $20.5K
Jul 11, 2022
Buy
Stock Option (Right to Buy)
A-Award
Ritter Ira E.
Director 40 000
Value: $0
Jul 11, 2022
Buy
Stock Option (Right to Buy)
A-Award
Arshad Tariq
SVP/chief Medical Officer
Officer 102 000
Value: $0
Jul 11, 2022
Buy
Stock Option (Right to Buy)
A-Award
Lotz Christopher L.
Vice President Of Finance, CFO
CEO / President 100 000
Value: $51.4K
Jul 11, 2022
Buy
Stock Option (Right to Buy)
A-Award
Lotz Christopher L.
Vice President Of Finance, CFO
CEO / President 100 000
Value: $0
Jul 11, 2022
Buy
Stock Option (Right to Buy)
A-Award
Abdul-ahad Wajdi
Vice President, R & D, Cso
CEO / President 80 000
Value: $0
Jun 22, 2022
Buy
Common Stock
P-Purchase
Poirier Michael S.
Chairman And CEO
CEO / President 30 000
Value: $17.1K
Jun 22, 2022
Buy
Common Stock
P-Purchase
Poirier Michael S.
Chairman And CEO
CEO / President 30 000
Value: $17.1K
Jun 14, 2022
Buy
Common Stock
P-Purchase
Broidrick Amy S.
President/cso
CEO / President 30 000
Value: $18.6K
Jun 14, 2022
Buy
Common Stock
P-Purchase
Broidrick Amy S.
President/cso
CEO / President 30 000
Value: $18.6K
Dec 08, 2021
Buy
Stock Option (Right to Buy)
A-Award
Broidrick Amy S.
President/chiefstrategyofficer
CEO / President 300 000
Value: $372.0K
Dec 08, 2021
Buy
Stock Option (Right to Buy)
A-Award
Arshad Tariq
SVP/chief Medical Officer
Officer 300 000
Value: $372.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT QUALIGEN THERAPEUTICS INC.
Qualigen Therapeutics
Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that block...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE